| |
Late Breaking
Clinical Trials and "First
Report" Investigations
Late
Breaking Randomized Trials
Main Arena
Monday, October
23, 2006
Plenary Session
4: Late Breaking Clinical Trials
I
Moderators: David J. Cohen and
Gregg W. Stone
11:00 am
ZOMAXX I—A Prospective,
Multicenter, Randomized Trial of
Zotarolimus- and Paclitaxel-Eluting
Stents in Patients With Coronary
Artery Disease: Nine-Month Clinical
and Angiographic Results
Bernard R. Chevalier
11:12 am
Critical Assessment of the
ZOMAXX I Trial
David J. Cohen
11:15 am
Moderated Q&A Roundtable
Discussion
11:20 am
LONG-DES-II—A Prospective,
Multicenter, Randomized Trial of
Sirolimus- and Paclitaxel-Eluting
Stents in Long Coronary Lesions:
Six-Month Clinical and Angiographic
Results
Seung-Jung Park
11:32 am
Critical Assessment of the
LONG-DES-II Trial
Jeffrey J. Popma
11:35 am
Moderated Q&A Roundtable
Discussion
11:40 am
NORDIC BIFURCATION—A Prospective,
Multicenter, Large-Scale, Randomized
Trial of Single vs Multiple Drug-Eluting
Stents in Bifurcation Lesions: Eight-Month
Angiographic and One-Year Clinical
Results
Andrejs Englis
11:52 am
Critical Assessment of the
NORDIC BIFURCATION Trial
Barry D. Rutherford
11:55 am
Moderated Q&A Roundtable
Discussion
Tuesday, October
24, 2006
TUESDAY,
OCTOBER 24, 2006
Plenary Session 13: Late Breaking
Clinical Trials II
Moderators: Spencer B. King
III and Martin B. Leon
11:00 am
ACUITY PCI—A Prospective
Trial of Patients With Acute Coronary
Syndromes Undergoing PCI After Randomization
to Heparin Plus Glycoprotein IIb/IIIa
Inhibitors vs Bivalirudin With or
Without Glycoprotein IIb/IIIa Inhibitors:
Thirty-Day Clinical and Angiographic
Core Laboratory Results
Gregg W. Stone
11:12 am
Critical Assessment of the
ACUITY PCI Trial
Eric J. Topol
11:15 am
Moderated Q&A Roundtable
Discussion
11:20 am
HAAMU-STENT—A Prospective,
Randomized Trial of Patients With
Acute Myocardial Infarction Randomized
to Paclitaxel-Eluting vs Bare-Metal
Stents: One-Year Clinical and Angiographic
Results
Ilkka Tierala
11:32 am
Critical Assessment of the
HAAMU-STENT Trial
David P. Faxon
11:35 am
Moderated Q&A Roundtable
Discussion
11:40 am
CIAO—A Prospective, Randomized,
Placebo-Controlled, Single-Center
Trial of Heparin vs No Heparin in
Patients Undergoing Percutaneous
Coronary Intervention
Eugenio Stabile
11:52 am
Critical Assessment of the
CIAO Trial
Deepak L. Bhatt
11:55 am
Moderated Q&A Roundtable
Discussion
Wednesday, October
25, 2006
Plenary
Session 22: Late Breaking Clinical
Trials III
Moderators: Bernard J. Gersh
and Gregg W. Stone
11:00 am
SORT OUT II—A Prospective,
Multicenter, Large-Scale, Randomized
Trial of Paclitaxel- and Sirolimus-Eluting
Stents in “Real-World” Lesions:
Nine-Month Clinical Results
Anders M. Galloe
11:12 am
Critical Assessment of the
SORT OUT II Trial
Patrick W. Serruys
11:15 am
Moderated Q&A Roundtable
Discussion
11:20 am
REPAIR MI LATE—A Prospective,
Multicenter, Randomized, Placebo-Controlled
Trial of Autologous Bone Marrow-Derived
Progenitor Cells in Patients With
Recent Myocardial Infarction: One-Year
Clinical Results
Andreas Zeiher
11:32 am
Critical Assessment of the
REPAIR MI LATE Trial
Bernard J. Gersh
11:35 am
Moderated Q&A Roundtable
Discussion
11:40 am
CARE—A Prospective, Randomized,
Placebo-Controlled Trial of Iopamidol
vs Iodixanol in Patients at Increased
Risk for Contrast Nephropathy
Richard Solomon
11:52 am
ICON—A Prospective, Randomized,
Placebo-Controlled Trial of Ioxaglate
vs Iodixanol in Patients at Increased
Risk for Contrast Nephropathy
Roxana Mehran
12:04 pm
Critical Assessment of the
CARE and ICON Trials
Cindy L. Grines
12:10 pm
Moderated Q&A Roundtable
Discussion
12:15 pm
Adjourn
“First Report” Randomized
Trials and Registries
Main Arena
Monday,
October 23, 2006
Moderators:
Martin B. Leon and David R. Holmes,
Jr
12:30 pm
DEScover—A Prospective,
Large-Scale, Multicenter Registry
With Sirolimus- and Paclitaxel-Eluting
Stents: One-Year Clinical Results
David O. Williams
12:42 pm
Critical Commentary of the
DEScover Registry
Michael J. Cowley
12:45 pm
MEDISTRA—First-in-Man Registry
With Bioabsorbable, Polymer-Based,
Sirolimus-Eluting Stents: Six-Month
Angiographic and Twelve-Month Clinical
Results
Teguh Santoso
12:57 pm
Critical Commentary of the
MEDISTRA Registry
Philip M. Urban
1:00 pm
THUNDER—A Prospective, Randomized
Trial of Paclitaxel-Coated Balloons
vs Noncoated Balloons in Patients
With Peripheral Arterial Disease:
Late Clinical and Angiographic Follow-Up
Gunnar Tepe
1:12 pm
Critical Commentary of the
THUNDER Trial
Ivan De Scheerder
1:15 pm
Impact of Pioglitazone on
Endothelial Function: A Prospective,
Placebo-Controlled, Randomized Trial
in Nondiabetic Patients
Jochen Wohrle
1:27 pm
Critical Commentary of the
Impact of Pioglitazone on Endothelial
Function Trial
Amir Lerman
1:30 pm
FAST LATE—A Prospective,
Randomized Trial of Balloon Angioplasty
and Nitinol Stents in the Superficial
Femoral Artery: Twelve-Month Results
Hans Krankenberg
1:42 pm
Critical Commentary of the
FAST LATE Trial
James D. Joye
1:45 pm
Adjourn
Tuesday,
October 24, 2006
Moderators:
Jean Marco and Gregg W. Stone
12:30 pm
VAMPIRE—A Randomized Trial
of Aspiration in Acute Myocardial
Infarction
Takaaki Isshiki
12:42 pm
Critical Commentary of the
VAMPIRE Trial
Michael Haude
12:45 pm
NOBORI 1—A Prospective,
Randomized Trial of Biolimus A9-
and Paclitaxel-Eluting Stents: Nine-Month
Clinical and Angiographic Follow-Up
Bernard R. Chevalier
12:57 pm
Critical Commentary of the
NOBORI 1 Trial
J. Eduardo M.R. Sousa
1:00 pm
ETHOS 1—A Prospective, Randomized
Trial of Estradiol-Eluting R Stents
Alexandre Abizaid
1:12 pm
Critical Commentary of the
ETHOS 1 Trial
Michael J.B. Kutryk
1:15
ABSORB—First-in-Man Registry
With BVS Bioabsorbable Stents: Thirty-Day
Safety Results
John A. Ormiston
1:27 pm
Critical Commentary of the
ABSORB Registry
Raimund A. Erbel
1:30 pm
BEST—First-in-Man Registry
With a Bioabsorbable PFO and ASD
Closure Device
Michael J. Mullen
1:42 pm
Critical Commentary of the
BEST Registry
Horst Sievert
1:45 pm
Adjourn
Wednesday,
October 25, 2006
Moderators:
Eberhard Grube and Gregg W. Stone
12:30 pm
TAXUS OLYMPIA—A Prospective,
Large-Scale, Multicenter Registry
With TAXUS Liberté Paclitaxel-Eluting
Stents: Six- and Twelve-Month Clinical
Results
Martyn R. Thomas
12:42 pm
Critical Commentary of the
TAXUS OLYMPIA Registry
J.J.R.M. (Hans) Bonnier
12:45 pm
TAXUS ATLAS WORKHORSE and
DIRECT: Prospective Registries of
TAXUS Paclitaxel-Eluting Liberte
Stent Implantation in Workhorse
Lesions and Without Predilitation:
Nine- and Twelve-Month Clinical
and Angiographic Results
Mark A. Turco
12:57 pm
Critical Commentary of the
TAXUS ATLAS WORKHORSE and DIRECT
Registry
Jeffrey W. Moses
1:00 pm
STENT-MULTIVESSEL—Comparison
of Multivessel Stent Implantation
With Paclitaxel
Charles A. Simonton
1:12 pm
Critical Commentary of the
STENT-MULTIVESSEL Study
Carlo Di Mario
1:15 pm
REWARDS—Non-Randomized Comparison
of Sirolimus- and Paclitaxel-Eluting
Stents in the Real World: One-Year
Results From a Large, Single-Center
Registry
Ron Waksman
1:27 pm
Critical Commentary of the
REWARDS Registry
William O’Neill
1:30 pm
RESOLUTE—First-in-Man Registry
With Endeavor CR Zotarolimus-Eluting
Stents: Four-Month Clinical, Angiographic,
and Intravascular Ultrasound Results
Ian T. Meredith
1:42 pm
Critical Commentary of the
RESOLUTE Registry
Alexandra J. Lansky
1:45 pm
Adjourn
|
|
